In May 2019 the International Association of Athletics Federations (IAAF) has reported an anti-doping rule violation against the Iranian Athlete Hosein Keyahni after his sample tested positive for the prohibited substance Erythropoietin (EPO). After notification the Athlete admitted the violation, waived his right to be heard, accepted a provisional suspension and the sanction proposed by the IAAF.
The Athlete denied the intentional use of the substance and explained that he had high altitude training and underwent medical treatment because he felt dizzy and had dyspnea and numbness. He demonstrated with medical evidence that his doctor administed prescribed EPO while he wasn’t aware that this was a prohibited substance.
Therefore the IAAF Athletics Integrity Unit (AIU) decides on 20 June 2019 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 21 May 2019.
